Yifan Pharmaceutical Co Ltd - Class A

SZSE:002019 (China)   Class A
Â¥ 11.05 (-1.34%) Dec 25
At Loss
P/B:
1.58
Market Cap:
Â¥ 13.44B ($ 1.87B)
Enterprise V:
Â¥ 14.96B ($ 2.05B)
Volume:
6.80M
Avg Vol (2M):
11.02M
Trade In:
Volume:
6.80M
At Loss

Business Description

Description
Yifan Pharmaceutical Co Ltd is a China-based company engaged in R&D and production company focusing on the pharmaceutical and health sectors. Its vision is to develop drugs with definite clinical values, to help disease-afflicted patients regain health. The group focuses on four business areas such as biologics, small molecules, synthetic biologics, and special traditional Chinese medicines (TCMs). The products of the company are Ryzneuta, Plerixafor Injection, Vincristine Sulfate, Skin Allergy Reli, and Others.
Name Current Vs Industry Vs History
Cash-To-Debt 0.43
Equity-to-Asset 0.69
Debt-to-Equity 0.3
Debt-to-EBITDA -4.57
Interest Coverage 5.32
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.9
Distress
Grey
Safe
Beneish M-Score -2.69
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 30.6
9-Day RSI 33.1
14-Day RSI 37.32
6-1 Month Momentum % -6.81
12-1 Month Momentum % -22.57

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.32
Quick Ratio 0.96
Cash Ratio 0.36
Days Inventory 136.64
Days Sales Outstanding 90.76
Days Payable 63.91
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Yifan Pharmaceutical Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ¥) 4,996.037
EPS (TTM) (Â¥) -0.27
Beta 1.54
Volatility % 50.28
14-Day RSI 37.32
14-Day ATR (Â¥) 0.297543
20-Day SMA (Â¥) 11.69
12-1 Month Momentum % -22.57
52-Week Range (Â¥) 9.11 - 15.3
Shares Outstanding (Mil) 1,216.39

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Yifan Pharmaceutical Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Yifan Pharmaceutical Co Ltd Stock Events

Financials Calendars
Event Date Price(Â¥)
No Event Data

Yifan Pharmaceutical Co Ltd Frequently Asked Questions

What is Yifan Pharmaceutical Co Ltd(SZSE:002019)'s stock price today?
The current price of SZSE:002019 is ¥11.05. The 52 week high of SZSE:002019 is ¥15.30 and 52 week low is ¥9.11.
When is next earnings date of Yifan Pharmaceutical Co Ltd(SZSE:002019)?
The next earnings date of Yifan Pharmaceutical Co Ltd(SZSE:002019) is .
Does Yifan Pharmaceutical Co Ltd(SZSE:002019) pay dividends? If so, how much?
The  Dividend Yield %  of Yifan Pharmaceutical Co Ltd(SZSE:002019) is 0.89% (As of Today), Highest Dividend Payout Ratio of Yifan Pharmaceutical Co Ltd(SZSE:002019) was 0.67. The lowest was 0.06. And the median was 0.15. The  Forward Dividend Yield % of Yifan Pharmaceutical Co Ltd(SZSE:002019) is 0.89%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release